Product Information
CHEST CONG RLF PE 400-10 MG TB is a generic product labeled by Rugby Laboratories, priced at $0.0786 per EA under NDC 00536130907. Its NADAC has been published 220 times since Aug 18, 2021.
Strength
400; 10 mg/1; mg/1
Manufacturer
Rugby LaboratoriesNDC
00536130907
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
10/22/2025
Active Ingredients
GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
9/9/2020
Pharmacological Classes
Price Statistics
The NADAC for CHEST CONG RLF PE 400-10 MG TB has been published 220 times since Aug 18, 2021, and over the history we have for it it has declined 9.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0786 per EA |
|---|---|
| All-time high | $0.0937 (Mar 16, 2022) |
| All-time low | $0.0697 (Dec 21, 2022) |
| 52-week high | $0.0868 |
| 52-week low | $0.0786 |
| Median price | $0.0817 |
| Average price | $0.0818 |
| Largest weekly change | +16.4% (Feb 22, 2023) |
| Weeks tracked | 220 |
| Tracking since | Aug 18, 2021 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CHEST CONG RLF PE 400-10 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for CHEST CONG RLF PE 400-10 MG TB, manufactured by Rugby Laboratories, is $0.0786 per EA (NDC 00536130907), effective Oct 29, 2025.
How has the price of CHEST CONG RLF PE 400-10 MG TB changed over time?
Over the history we have for it, the NADAC for CHEST CONG RLF PE 400-10 MG TB has declined 9.4%. It has been tracked across 220 weekly CMS publications since Aug 18, 2021.
What are the highest and lowest recorded NADAC prices for CHEST CONG RLF PE 400-10 MG TB?
Since Aug 18, 2021, the NADAC for CHEST CONG RLF PE 400-10 MG TB has ranged from a low of $0.0697 (Dec 21, 2022) to a high of $0.0937 (Mar 16, 2022), with a median of $0.0817 per EA.
Are there cheaper alternatives to CHEST CONG RLF PE 400-10 MG TB?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, SM CHEST CONG RELIEF PE CAPLET, is $0.0697 per EA — about 11% below CHEST CONG RLF PE 400-10 MG TB.
Who manufactures CHEST CONG RLF PE 400-10 MG TB?
CHEST CONG RLF PE 400-10 MG TB (NDC 00536130907) is labeled by Rugby Laboratories, and CMS classifies it as a generic product.
Related Drugs
Same classification